Puma Biotechnology (PBYI) Times Interest Earned (2018 - 2026)
Puma Biotechnology (PBYI) reported Times Interest Earned of -$5.24 for Q1 2026, down 386.15% on a YoY basis from $1.83 in Q1 2025, and down 134.26% quarter-over-quarter from $15.29 in Q4 2025.
Puma Biotechnology (PBYI) Times Interest Earned (2018 - 2026) Analysis & Trends
Puma Biotechnology has reported Times Interest Earned for 9 years, with the latest figure at -$5.24 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 386.15% year-over-year to -$5.24; the trailing twelve-month figure through Mar 2026 stood at $5.7 (up 72.36% YoY), and the FY2025 full-year result was $5.63, up 126.5% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$5.24, down from $15.29 in the prior quarter.
- The five-year high for Times Interest Earned was $15.29 in Q4 2025, with the low at -$5.24 in Q1 2026.
- Historically, Times Interest Earned has averaged $2.98 across 5 years, with a median of $2.57 in 2023.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 1750.57% — and 2026, when it slumped 386.15%.
- Puma Biotechnology's Times Interest Earned stood at $3.05 in 2022, then soared by 44.44% to $4.41 in 2023, then climbed by 15.57% to $5.1 in 2024, then surged by 199.79% to $15.29 in 2025, then sank by 134.26% to -$5.24 in 2026.
- The last three Times Interest Earned figures came in at -$5.24 (Q1 2026), $15.29 (Q4 2025), and $6.43 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | -5.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.24 |
| Dec 31, 2025 | 15.29 |
| Sep 30, 2025 | 6.43 |
| Jun 30, 2025 | 3.61 |
| Mar 31, 2025 | 1.83 |
| Dec 31, 2024 | 5.10 |
| Sep 30, 2024 | 7.12 |
| Jun 30, 2024 | -0.65 |
| Mar 31, 2024 | -0.68 |
| Dec 31, 2023 | 4.41 |
| Sep 30, 2023 | 2.57 |
| Jun 30, 2023 | 1.47 |
| Mar 31, 2023 | 1.32 |
| Dec 31, 2022 | 3.05 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 4.46 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.19 |
| Sep 30, 2021 | -2.87 |
| Jun 30, 2021 | -4.73 |